Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray reality checks in the context of a complex disease.

George L Gabor Miklos1, Ryszard Maleszka

  • 1Secure Genetics, 81 Bynya Road, Palm Beach, Sydney, NSW, Australia. gmiklos@securegenetics.com

Nature Biotechnology
|May 4, 2004
PubMed
Summary

Microarray gene expression analysis struggles to distinguish causal disease genes from bystander genes. Clinical and biological data rarely prioritize the same genes as microarrays, hindering disease research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-biased DNA methylation in small hive beetles (Aethina tumida).

Insect molecular biology·2026
Same author

The multisensory basis of long-distance migration in monarch butterflies and bogong moths: precision navigation or simply chance?

The Journal of experimental biology·2026
Same author

Still no evidence for an environmentally responsive epigenetic clock in an insect.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Is the concept of mammalian epigenetic clocks universal and applicable to invertebrates?

Frontiers in genetics·2025
Same author

Reminiscences on the honeybee genome project and the rise of epigenetic concepts in insect science.

Insect molecular biology·2024
Same author

The PWWP domain and the evolution of unique DNA methylation toolkits in Hymenoptera.

iScience·2023

Area of Science:

  • Genomics
  • Systems Biology
  • Neuroscience

Background:

  • Analyzing gene expression data from microarrays is challenging for identifying disease-causal genes versus secondary bystander genes.
  • Complex human diseases, such as schizophrenia, require robust methods to differentiate primary molecular alterations from downstream effects.

Purpose of the Study:

  • To systematically compare gene prioritization from microarray data with non-microarray clinical and biological data in schizophrenia.
  • To assess the concordance between microarray findings and other data types across various human diseases and model organisms.

Main Methods:

  • Comparative analysis of gene expression data from microarrays against clinical, in situ, molecular, single-nucleotide polymorphism (SNP) association, knockout, and drug perturbation data.
  • Evaluation of microarray data validation using genome-wide phenotypic data in model organisms.

Related Experiment Videos

  • Assessment of the impact of different bioinformatics protocols on gene set generation from identical microarray data.

    • Main Results:

    • Genes identified as important by microarrays were seldom prioritized by clinical, molecular, or genetic association data for schizophrenia.
    • This discrepancy was observed across multiple human disease datasets and in biological validation studies using model organisms.
    • Varying bioinformatics protocols produced significantly different gene sets from the same microarray data, complicating clinical interpretation.

    Conclusions:

    • Microarray gene expression data alone may not reliably identify disease-causal genes when compared to established clinical and biological evidence.
    • Improved clinical relevance of microarray studies may be achieved by integrating high-quality phenotypic data with gene expression findings.
    • Further research is needed to reconcile discrepancies between high-throughput molecular data and traditional biological and clinical data in disease analysis.